BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.74
-0.44 (-4.79%)
At close: Aug 28, 2026, 4:00 PM EDT
8.91
+0.17 (1.95%)
After-hours: Aug 28, 2026, 7:30 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $700.72 million as of August 28, 2026. Its market cap has decreased by -4.86% in one year.
Market Cap
700.72M
Enterprise Value
359.11M
1-Year Change
-4.86%
Ranking
Category
Stock Price
$8.74
ChartMarket Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $700.72M, an increase of 1,733.75%. That is a compound annual growth rate of 212.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 700.72M | -30.03% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 732.02M |
| Phathom Pharmaceuticals | 729.17M |
| Shattuck Labs | 706.56M |
| Obsidian Therapeutics | 706.22M |
| MapLight Therapeutics | 700.25M |
| CytomX Therapeutics | 699.46M |
| Gyre Therapeutics | 698.76M |
| Allogene Therapeutics | 697.89M |